Legend Biotech Co. (NASDAQ:LEGN – Get Free Report) has received an average recommendation of “Buy” from the fourteen ratings firms that are covering the stock, Marketbeat reports. Fourteen research analysts have rated the stock with a buy rating. The average 1-year target price among brokerages that have updated their coverage on the stock in the […]